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Bacillus subtilis has been extensively studied and serves as a model organism for 
Gram-positive bacteria which can be attributed to its capacity to be genetically 
manipulated, form endospores, and a sequenced genome. B. subtilis undergoes a 
disproportionate cellular division during a process known as sporulation, which has been 
widely used to study more complex phenomena, such as cellular differentiation. In 
addition, B. subtilis is widely used by industry and a greater understanding of its 
metabolic pathways would be a valuable contribution to the genomic annotation in this 
model organism. 
A long-term goal of our research is to provide a more complete description of the 
biochemical pathways that are encoded by the mother cell metabolic gene (mmg) operon 
within B. subtilis. One specific objective of this research is to compare the 2-
methylcitrate stereoisomer produced by 2-methylcitrate synthase, the PrpC enzyme, in 
Escherichia coli to the 2-methylcitrate stereoisomer produced by the homologous 
enzyme, MmgD, in B. subtilis. In addition, we wish to further investigate the subsequent 
dehydration reaction catalyzed by homologous enzymes PrpD and MmgE, which both 
have been found to produce (Z)-2-methylcitrate. The prpC and prpD gene products were 
cloned, overexpressed, and purified using a culture of E. coli strain BL21(DE3) via 
methods established by researchers of the Reddick Lab. The presence of the desired prpC 
and prpD gene products were verified by SDS-PAGE analysis and activity assays. 
	  
To compare the 2-methylcitrate synthase activity of PrpC to MmgD, the reaction 
product was assessed by standardization with commercially available 2-methylcitrate 
racemate. Activity assays with PrpD and cross-species experiments were prepared in the 
same manner. Using this methodology, it was found that PrpC and MmgD produce either 
(2S, 3R)-2-methylcitrate or (3S, 2R)-2-methylcitrate. In addition, by confirming the 
substrates for these enzymes, we demonstrated the substrate for PrpD is not (2S, 3S)-2-
methylcitrate and, therefore, PrpD does not exhibit a syn-elimination mechanism to 
produce (Z)-2-methylcitrate.
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CHAPTER I 
 
INTRODUCTION 
 
 
1.1 Review of Literature 
1.1.1 Overview and Applications of Bacillus subtilis 
As a Gram-positive, rod-shaped endospore forming bacterium, Bacillus subtilis 
has been extensively studied and serves as a model organism which can be attributed to 
its capacity to be genetically manipulated.1 Although, B. subtilis can be found in a wide 
range of environments, growth is associated with the presence of decomposing organic 
matter, such as that found in soil and the gastrointestinal tract of certain animals.2 In 
1997, B. subtilis became the first Gram-positive bacterium to have its genome sequenced 
and consists of 4,100 protein-coding genes.3 B. subtilis has historically been classified as 
a strict aerobe, but there is evidence of anaerobic growth in the presence of nitrate.4 
As the first Gram-positive bacterium to have its genome sequenced, B. subtilis has 
proven to be a versatile and valuable model organism in a number of capacities including, 
food safety, vaccine development, and enzyme production.3 The bacterium has been 
classified as “Generally Recognized as Safe” by the Food and Drug Administration.5 It is 
readily used in food safety techniques, such as involvement in food fermentation and 
post-harvest produce washing.5 The industrial enzymes, Carbohydrase and protease 
produced by B. subtilis have been deemed by the FDA to be nonpathogenic and 
nontoxicogenic.6  Enzymes that B. subtilis produces, such as proteases and amylases, 
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have also been found to be useful in industry.7 The wide use of B. subtilis in both 
industry and academia points to the importance of elucidating metabolic pathways and 
genetic strategies of this model organism. 
1.1.2 Summary of Sporulation 
Under strenuous conditions that are not conducive with vegetative life, such as the 
absence of a carbon or nitrogen source, B. subtilis will undergo sporulation, which is an 
uneven cellular division, in which the size and composition of the cells differ.8 The 
process of sporulation initially produces a mother cell and a forespore.9 Once sporulation 
is completed, a dormant and resilient structure, known as a spore, is produced that has 
been estimated to survive for up to thousands of years.9 The initiation of this 
asymmetrical division is regulated by the SpoOA master transcription factor that 
becomes phosphorylated as a result of harsh environmental conditions and initiates 
sporulation-specific gene expression.9 Along with kinase events, SpoOA plays an integral 
role in the decision to undergo sporulation.9 Once the septum has been formed, the first 
compartment-specific transcription factor activated is σF and is responsible for the 
subsequent activations of other transcription factors, including σE, σG, and σK.9 The first 
mother-cell-specific transcription factor is σE, which upon activation leads to the 
expression of genes within the mother metabolic gene (mmg) operon.10 This gene cluster 
has been characterized by the work conducted within the laboratory of Dr. Jason 
Reddick.11 
The asymmetric division that B. subtilis undergoes during sporulation has been 
used to study more complex phenomena, such as, cellular differentiation.12 Also, it has 
	  3	  
been observed that sporulation-specific proteins may have homologous activity to 
proteins present during normal growth.9 Sporulation is a conserved feature amongst other 
species including Bacillus anthracis.13 Although the morphological features of 
sporulation have been studied extensively, there are still many poorly understood 
biochemical pathways that occur during sporulation. 
1.1.3 Genetic Regulation of the Methylcitric Acid Cycle 
The metabolism of propionate, a short chain odd-carbon fatty acid, via the 
methylcitric acid cycle (MCC) was first identified in Yallowia lipolytica.14 The 
propionate (prp) operon, which codes for five enzymes involved in the MCC, has been 
studied in other species including, Salmonella typhimurium LT2 and Escherichia coli.15,16 
The prp locus consists of two transcriptional units involved in propionate degradation.15 
The portion known as, prpR has been shown to initiate transcription of the other portion 
of the prp locus, prpBCDE.15 In addition, the σE dependent mmg operon found in B. 
subtilis contains fatty-acid metabolizing enzymes and prp homologs, specifically those 
involved in the MCC.10,11 The prp operon in E. coli compared to the mmg operon found 
in B. subtilis is pictured in Figure 1. The proteins encoded by prpC from E. coli and 
mmgD from B. subtilis share an amino acid sequence identity of 34% and 75% overall 
similarity. Homology of prpD in E. coli and mmgE in B. subtilis has previously been 
reported; these enzymes share a 61% amino acid sequence identity and 75% overall 
sequence similarity.17 
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Figure 1. Comparison of Propionate Operon and Mother Cell Metabolic Gene 
Operon. A: Illustration of mmg operon from B. subtilis responsible for fatty-acid 
degradation. B: Scheme of the prp operon from E. coli involved in propionate oxidation. 
 
A generic representation of propionate degradation via the MCC involving either 
prp or mmg operon encoded enzymes is shown in Figure 2. This metabolic pathway 
begins with the gene product of prpE, propionyl-CoA synthetase, which catalyzes the 
reaction using substrates propionate, coenzyme A, and adenosine triphosphate to produce 
propionyl-CoA.15 The following step is catalyzed by the gene product prpC, 2-
methycitrate synthase, which is the condensation of propionyl-CoA with oxaloacetate  
producing 2-methylcitrate.15 The sequential step involves the dehydration of 2-
methylcitrate by 2-methylcitrate dehydratase, the gene product of prpD, to form (Z)-2-
methylaconitate. The following reaction is catalyzed by an aconitase that converts 2-
methylcitrate to 2-methylisocitrate.17 The final step in the MCC involves 2 methylcitrate 
lyase, the gene product prpB, that produces succinate and pyruvate.15 
mmgA
prpR prpB prpC prpD prpE
Bacillus subtilis
Escherichia coli
mmg operon
prp operon
mmgB mmgC mmgD mmgE yqiQA
B
	  5	  
 
 
Figure 2. The Degradation of Propionate Via the Methylcitric Acid Cycle. 
 
1.1.4 Previous MCC Results Obtained from B. subtilis 
The genes encoding the enzymes responsible for carrying out the MCC have been 
characterized, enzyme activity investigated, and homologous genes determined within 
other species.18 The MCC has most recently been studied in B. subtilis.11 B. subtilis has 
exhibited homologous gene products that have been previously identified in S. 
typhimurium and E. coli.17 Despite reports of homology between B. subtilis and E. coli, 
there does appear to be a discrepancy between the products and substrates of two specific 
steps within the MCC. It was reported that the gene product of prpC, 2-methylcitrate 
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synthase in E. coli catalyzed a condensation reaction that produced (2S, 3S)-2-
methylcitrate, which was “verified” by enantioselective multidimensional capillary gas 
chromatography.17 Unfortunately, there was no data reported with this claim. Also, the 
stereo assignment of (2S, 3S)-2-methylcitrate as the substrate for the gene product of 
prpD, 2-methylcitrate dehydratase, was reinforced by the observed maximum activity. 
Listed was substrate specificity for a variety of compounds, but there was no data listed 
for the activity of PrpD using (2SR, 3RS)-2-methylcitrate.17 In addition, there were no 
activity values reported for authentic (Z)-2-methylaconitate, due to unavailability 
reported by the author. It has been previously stated that PrpD demonstrates substrate 
specificity for (2S, 3S)-2-methylcitrate only.17 The reaction of this particular enzyme 
would therefore exhibit a syn-elimination mechanism, which is peculiar.17 Illustrated by a 
Newman projection shown in Figure 3, is the eclipsed conformation that would be 
necessary for the reaction to proceed through syn-elimination.17 If in fact PrpD underwent 
a syn-elimination mechanism, it would be considered a novel dehydratase. 
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Figure 3. The Previously Reported Syn-elimination Mechanism of PrpD, 2-
Methylcitrate Dehydratase. The proposed substrate of PrpD (2S, 3S)-2-methylcitrate 
(1), also portrayed as a Newman projection (2), producing exclusively (Z)-2-
methylaconitate (3). 
 
Conflicting chromatography results obtained from B. subtilis are illustrated in 
Figure 4. The chromatograph of a commercially available racemic mixture of` (2SR, 
3RS)-2-methylcitrate and (2SR, 3SR)-2-methylcitrate is shown in Figure 4A. Depicted in 
Figure 4B, MmgD from B. subtilis was shown to catalyze the condensation of propionyl-
CoA reacting with oxaloacetate to form (2S, 3R)-2-methylcitrate or (2R, 3S)-2-
methylcitrate.11 The 2-methylcitrate dehydratase in E. coli, PrpC was reported to produce 
(2S, 3S)-2-methylcitrate, which corresponds to the product peak at 16.2 minutes.17 This is 
the preceding step to the dehydration reaction catalyzed by the gene product of mmgE 
from B. subtilis. As shown in the chromatogram in Figure 4C, it was observed that 
MmgE, using the mixture of diastereomers of 2-methylcitrate standard as its substrate, 
catalyzed the elimination of water resulting in the formation of two products (Z)-2-
CO2
HOH
CO2
CO2 H2O
O2C
(Z)
O2C
CO2
(S)
(S)
O2C
CO2
H
HO
O2C
syn-
elimination
1 2 3
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methylaconitate and (E)-2-methylaconitate.11 The active peaks at 13.6 and 16.3 minutes 
indicate unreacted starting material. 
 
 
Figure 4. HPLC Chromatograms from Bacillus subtilis Enzymes, MmgD and 
MmgE. A: HPLC chromatogram of 2-methylcitrate racemate, including four 
stereoisomers, (2SR, 3RS) as the minor product and (2SR, 3SR) as the major product. B: 
Chromatography of substrates propionyl-CoA and oxaloacetate being supplied to MmgD. 
C: The chromatogram of the full MmgE reaction with the commercial 2-methylcitrate as 
the substrate source. The new product peaks at 16.5 and 19.6 minutes correspond to (Z)-
2-methylaconitate and (E)-2-methylaconitate respectively. D: Chromatogram of full 
MmgD and MmgE reaction with propionyl-CoA and oxalacetate only as the substrates 
displaying one new product peak at 16.5 minutes. 
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The sequence identities of mmgE and prpD support the conclusion that these 
proteins would have similar enzymatic behavior. Based on this reasoning, either the 
stereochemical conclusion for B. subtilis has been incorrectly assigned or the 
stereochemistry provided by the literature for E. coli has been misassigned. 
1.2 Central Hypothesis and Objectives 
 Despite the precedence within the literature and the previous results observed 
with B. subtilis, the central hypothesis of this project is mmgD and mmgE in Bacillus 
subtilis and prpC and prpD in Escherichia coli are genes that encode for homologous 
enzymes that produce the same stereoisomer products.  
One objective of our current work is to compare the stereoselectivity of 2-
methylcitrate synthase from B. subtilis and E. coli using the same methodology as in our 
laboratory’s work with B. subtilis. In this specific objective, the gene sequence of 
interest, prpC, was isolated from the prp operon in E. coli. This gene has exhibited 
similarities to methylcitrate synthases in other species including S. enterica and B. 
subtilis. PrpC was acquired through recombinant DNA methods. The reaction products of 
PrpC from E. coli and MmgD from B. subtilis were compared using HPLC methods 
already developed in our laboratory. 
In addition, we have been interested in investigating 2-methylcitrate dyhydratase 
from B. subtilis and E. coli. The subsequent step to the condensation of propionyl-CoA in 
the MCC is the dehydration of 2-methylcitrate. The substrate of the gene product of 
prpD, 2-methylcitrate dehydrates, in E. coli is 2-methylcitrate. PrpD from E. coli was 
obtained through cellular transformation and protein purification. To reveal whether 
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MmgD from B. subtilis and PrpC from E. coli are producing the same stereoisomer, 
HPLC was used to determine the reaction product of PrpD when supplied with 2-
methylcitrate produced by PrpC. Cross-species experiments were used to confirm 
whether these enzymes are interchangeable and producing the same compounds.
	  11	  
CHAPTER II 
EXPERIMENTAL 
	  
	  
2.1 prpC Gene Cloning 
2.1.1 Primer Design for prpC 
Primers for the gene prpC were designed using the genomic sequence of E. coli 
strain K12 (ECK12) and Bioedit Software. All primers had a Tm of approximately 60 °C 
and ranged from 21 to 34 base pairs in length. The oligomers designed for the gene prpC 
consisted of the following sequences: prpC forward: 5’-CAC CAT GAG CGA CAC 
AAC GAT CC-3’, and prpC reverse: 5’-TTA CTG GCG CTT ATC CAG CGC-3’. The 
CACC base pair sequence is added to the forward primer to enable the overhang of the 
pET-200 vector to invade the PCR product and propagate the proper insertion of the 
sequence. 
2.1.2 DNA Amplification of prpC via PCR 
Lysogeny Broth (LB), 5 mL, was inoculated with ECK12 and grown at 37 °C 
overnight. The genomic DNA from ECK12 was isolated using the Wizard® Genomic 
DNA Purification Kit procedure, according to the manufacturer’s instructions. The gene 
prpC was then amplified using PCR, the mixture included 2 µL of purified genomic 
DNA, 3 µL of each prpC forward and reverse primer, 17 µL of nanopure water, and 25 
µL of Phusion® High-Fidelity PCR MM w/HF-Buffer, which brought the total volume of 
the reaction to 50 µL. Thermocycler settings were adjusted to the following conditions: 
	  12	  
one cycle consisting of 98 °C for 30 seconds, 30 cycles of 98 °C for 5 seconds, 58 °C for 
10 seconds, 72 °C for 75 seconds, an additional cycle at 72 °C for 10 seconds, and 
concluding with a temperature setting at 4 °C. The fresh PCR product was purified by the 
Qiagen® QIAquick PCR Purification Kit, according to the manufacturer’s instructions. 
DNA amplification was confirmed by 1% agarose gel electrophoresis in 1X TAE 
buffer with visualization by ethidium bromide. To prepare samples, 4 µL of Gel Loading 
Dye (6X), 4 µL of nanopure H2O, and 16 µL of each sample were combined. The 
standard ladder sample was prepared with 1 µL of 2-Log DNA Ladder, 4 µL of dye, and 
4 µL of nanopure H2O. The gel was carried out at 120V in 1X TAE buffer. 
2.1.3 Vector and Cell Transformation of prpC 
The prpC TOPO® Cloning Reaction was performed using the following volumes 
of reagents: 3.35 µL of sterile H2O, 1 µL of salt solution, 0.65 µL of fresh PCR product, 
and 1 µL of TOPO® vector, and all were combined which brought the final volume to 6 
µL. The reaction was incubated at ambient temperature for 5 minutes. The One Shot® 
Top10 Chemical Transformation Protocol was followed by adding 3 µL of the TOPO® 
Cloning Reaction into a thawed vial of One Shot® Top10 Chemically Competent E. coli 
and incubated for 30 minutes on ice. The procedure was carried out in accordance to the 
manual with the exception of the entire vial being plated onto a prewarmed selective plate 
instead of only 100-200 µL of transformation being plated. After an overnight incubation 
at 37 °C, 5 colonies were selected from the plated One Shot® Top10 Chemically 
Competent E. coli and grown in 5 mL of LB broth and 5 µL of kanamycin (0.5mg/mL). 
The starter cultures were centrifuged and the supernatant was discarded. In order to 
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screen for successful clones, the Qiagen QIAprep® Miniprep Kit protocol was followed 
and the purified plasmid products were analyzed. An additional PCR was carried out as 
stated before, with the exception of one plasmid specific primer with one gene specific 
primer (T7 and prpC) in place of the gene specific primers. An electrophoresis gel was 
carried out to identify plasmids containing the prpC gene sequence. Plasmids indicating 
gene insertion by gel electrophoresis results were sent to be sequenced to verify proper 
reading frame position. 
2.2 prpD Gene Cloning 
2.2.1 Primer Design for prpD 
 The PCR oligomers for the gene prpD were designed using the following 
sequence: prpD reverse: 5’-TTA AAT GAC GTA CAG GTC GAG ATA CTC ATT 
GAC-3’, prpD forward: 5’-CAC CAT GTC AGC TCA AAT CAA CAT CC-3’ 
2.2.2 DNA Amplification of prpD via PCR 
The same procedure mentioned previously was followed with the exception of 
using the prpD forward and reverse primers in place of the prpC primers for the PCR. 
2.2.3 Vector and Cell Transformation of prpD 
Following the manufacturer’s protocol, the PCR product was cloned into pET-200 
using topoisomerase based cloning methodology. The manufacturer’s instructions 
provided a range for the concentration of fresh PCR product to add to the TOPO® 
Cloning Reaction. To obtain a proper ratio of PCR product to vector, two molar ratios of 
purified PCR product were used to TOPO® Clone into the pET-200 TOPO® vector. The 
1:1 molar ratio of PCR product to TOPO® vector contained: 3 µL of H2O, 1 µL of salt 
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solution supplied in the kit, 1 µL of purified PCR product, and 1 µL of vector. To prepare 
the 1:2 molar ratio sample, 2 µL H2O was added to 1 µL of salt, followed by the addition 
of 2 µL of diluted purified PCR product, and lastly 1 µL of vector was added. The only 
successful prpD TOPO® Cloning Reaction was accomplished by obtaining the 
concentration of the prpD PCR product and calculating the volume needed to fall within 
the desired range of 0.5:1 to 2:1 molar ratio of PCR product: TOPO® vector One Shot®. 
The TOPO® Cloning Reaction was performed using the following quantities of reagents: 
3.5 µL of nanopure H2O, 1 µL of Salt Solution, 0.5 µL of fresh prpD PCR product, and 1 
µL of TOPO vector. The reaction was allowed to incubate at ambient temperature for 5 
minutes. TOP10 Chemical Transformation Protocol was then followed by adding 3 µL of 
the different molar ratio TOPO® Cloning Reactions to separate vials of One Shot® 
TOP10 Chemically Competent E. coli and mixed gently with a pipette tip. The protocol 
was completed by spreading the entire transformation reaction onto a prewarmed LB agar 
plate containing (0.5 mg/mL) and incubated overnight.  
To screen for successful transformation, several colonies were selected from each 
plate to inoculate a mixture of 5 mL of LB broth and 5 µL of kanamycin (0.5 mg/mL), 
which were shaken and grown overnight at 37 °C. The starter cultures were centrifuged 
and the supernatant was discarded. The pellet was resuspended followed by the protocol 
of the Qiagen QIAprep® Miniprep kit and the purified plasmid products were analyzed. 
Similar to the protocol followed with prpC transformants, the plasmids containing the 
prpD gene were identified with electrophoresis gels of the PCR products using vector and 
prpD gene specific primers. 
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2.3 Protein Overexpression and Purification 
2.3.1 PrpC Protein Expression and Purification 
 To overexpress PrpC, BL21 Star™ (DE3) One Shot® Cells were used as the host 
strain. As instructed by the manufacturer’s protocol, 1 µL of the purified plasmid was 
added to the cells and the remaining procedure carried out. The entire transformation 
reaction was plated onto a prewarmed LB agar plate containing kanamycin (0.5 mg/mL). 
One colony was selected and used to inoculate a starter culture made up of 5 mL of LB 
broth and 5 µL of kanamycin (0.5 mg/mL). A large culture flask was prepared with 1 L of 
LB broth, 1000 µL of kanamycin (0.5 mg/mL), and 2 µL of the starter culture. This 
culture was allowed to grow at 37 °C until an absorption value of 0.526 at 595 nm was 
reached. The large culture was then induced with 0.238 g of IPTG and allowed to grow 
for an additional 3 hours at 37 °C. Using a JA-10 rotor, the sample was centrifuged at 
6500 rpm for 30 minutes at 4°C. After the supernatatant was discarded by decanting, the 
cell pellet was stored at -80 °C. 
One cell pellet was resuspended in 10 mL of 1X binding buffer consisting of 0.5 
M NaCl, 20 mM Tris buffer, and 5 mM imidazole (pH=8). The cell suspension was 
sonicated on ice for 3 minutes total, cycling between 30 second intervals of sonication 
and rest. The cell lysate was centrifuged using a JA-20 rotor at 11,500 rpm for 30 minutes 
at 4 °C . Using a syringe filter, the supernatant was filtered and loaded onto an Ni-NTA 
affinity column equilibrated in binding buffer. To ensure proper binding of PrpC protein 
to the column, 20 mL of 1X binding buffer was loaded onto the column, followed by 12 
mL of wash buffer (0.5 M NaCl, 20 mM Tris Buffer, and 60 mM imidazole, pH 8). To 
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elute, 12 mL of elution buffer (0.5 M NaCl, 20 mM Tris Buffer, and 200 mM imidiazole, 
pH 8) was loaded onto the column and seven 1 mL fractions were collected. After the 
fractions have been collected, 1 µL of Bradford reagent was added to 33 µL of each 
fraction to test for the presence of protein in the fractions. The fractions that contained 
protein indicated by the Bradford reagent changing from a reddish/brown color to a 
brilliant blue were then combined and dialyzed in 4 L of nanopure water and 12.14 g of 
Trizma Base, pH 8.5 overnight at 6 °C. After dialysis, 2.2 mL of solution was collected 
and protein aliquots were prepared containing 10% glycerol and stored at -80 °C. Using a 
Bradford Standard (BSA) method, the concentration of the collected protein was 0.7134 
mg/mL with a total of 1.6 mg of protein being collected per 500 mL of total culture . 
2.3.2 PrpD Protein Expression and Purification 
After confirming a positive clone via sequencing data, 1 µL of the isolated pure 
plasmid DNA was used in the protocol Transforming BL21 Star™ (DE3) One Shot® 
Cells. Starter cultures were inoculated with the same protocol as previously mentioned, 
which were then shaken and grown overnight at 37 °C. The large 1L culture was prepared 
as stated previously. Several growth parameters were implicated. The large culture was 
allowed to grow at 37 °C until the optical density reached 0.3 and then the temperature 
was lowered to 18 °C until an absorption reading between 0.5 and 0.6 at 595 nm was 
reached. The large culture was then induced with 0.238 g of IPTG and allowed to grow 
overnight at 18 °C. Several parameters of growth conditions were altered, and the highest 
and purest concentration of PrpD protein was achieved when the large culture was grown 
at a constant 37 °C until its optical density at 595 nm reached 0.511, at which point 
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0.238g of IPTG was added and the culture was permitted to shake at 200 rpm and grow 
overnight. Using a JA-10 rotor, the sample was centrifuged at 6,500 rpm for 30 minutes 
at 4 °C. The supernatant was disposed of by decanting and the cell pellet was stored in 
the -80 °C.  
The pellet was thawed and resuspended in 10 mL of 1X binding buffer. The 
sample was then sonicated on ice for a total of 5 minutes by alternating cycles of 30 
seconds on and 30 seconds of rest. The lysate was then centrifuged using a JA-20 rotor at 
11,500 rpm for 30 minutes. The supernatant was then syringe filtered using a 0.45 micron 
filter and loaded onto a 2 mL Ni-NTA Agarose column for purification. After the 
supernatant was allowed to pass through the column, 20 mL of 1X binding buffer was 
applied to the column followed by 12 mL of wash buffer, and approximately 10 mL of 
200mM elution buffer. The fractions were collected 1 mL at a time and 2 of the 8 factions 
exhibited a brilliant blue color upon addition of the Bradford reagent. The two fractions 
were combined and dialyzed overnight using SnakeSkin™ Dialysis Tubing in a 4 L 
solution of 25 mM Tris-HCl buffer at a pH of 8.25 at 6 °C. Aliquots were prepared with 
10% glycerol and stored at -80 °C until further analysis. 
2.4 Activity Assays 
2.4.1 Activity Assays with Purified 2-methylcitrate Synthase and 2-methylcitrate 
Dehydratase 
To determine the stereochemical outcome of the gene product of PrpC and PrpD, 
High Performance Liquid Chromatography with UV detection (HPLC-UV) experiments 
were conducted with a 250 x 4.6 mm Synergi 4m Hydro-RP 80A column using a Varian 
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Prostar HPLC. Analytical Liquid Chromatography - High performance liquid 
chromatography with UV detection (HPLC-UV).  HPLC with UV detection was 
conducted on a Varian Prostar HPLC with a 250 x 4.6 mm Synergi 4m Hydro-RP 80A 
column (Phenomenex, Torrence, CA). The chromatography solvents were as follows: 
Solvent A: 20 mM sodium phosphate in water, pH 2.91 and Solvent B: methanol.  A 
gradient elution was employed as follows: after injection, Solvent B (methanol) was 
increased from 0-15% over 20 minutes. All of the products eluted in this time, but 
unreacted acyl-CoA substrates were retained on the column and were eluted with a 
methanol flush involving a linear increase to 60% Solvent B from 20-25 minutes, held at 
60% from 25-35 minutes, followed by a linear decrease to 0% Solvent B from 35-40 
minutes, which was held for another 10 minutes at 100% Solvent A until the next 
injection.  Prior to injecting the samples onto the HPLC column, they were quenched by 
the addition of 1 M sodium phosphate buffer at pH 2.9 (100 mL per 1 mL of sample).  
The addition of this phosphate buffer was critical to achieving consistent separation and 
peak-shape during the HPLC elution.  The identity of reaction mixture constituents were 
assigned using retention times of standards of CoA, acetyl CoA, propionyl CoA, 
oxaloacetate, citric acid, cis-aconitate, trans-aconitate, succinate, pyruvate, and 2-
methylcitric acid (a commercial mixture of diasteromers as described above).  
Unfortunately standards of 2-methylaconitate or 2-methylisocitrate were not 
commercially available. 
The method for all activity assays contained the following chromatography 
solvents: Solvent A: 20 mM sodium phosphate, pH 2.91 and Solvent B: HPLC grade 
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methanol. Several methods and various buffers were tried in order to optimize HPLC 
conditions. Depicted in Table 1 are various reaction conditions that were implemented in 
order to obtain clear reproducible chromatography. 
 
Table 1. Various Reaction Conditions Implemented to Analyze Enzyme Activity. 
 First Condition Second Condition 
Third 
Condition 
Fourth 
Condition 
Reaction Buffer 200 mM Tris-HCl pH = 7.4 
10 mM Tris-
HCl pH = 7.4 
20 mM Sodium 
Phosphate  
pH = 7.4 
10 mM HEPES 
pH = 7.2 
Final Propionyl-CoA 
Concentration 5 mM 10 mM 10 mM 10 mM 
Final Oxaloacetate 
Concentration 20 mM 20 mM 20 mM 20 mM 
Final 2-methylcitrate 
Concentration 5 mM 1 mM 1 mM 1 mM 
Enzyme Volume 50 µL 50 µL 75 µL 75 µL 
Reaction Quenching 
Solution 
20 mM Sodium 
Phosphate  
pH = 2.95 
20 mM Sodium 
Phosphate 
pH = 2.95 
100 mM Sodium 
Phosphate  
pH = 2.95 
1 M Sodium 
Phosphate  
pH = 2.95 
Incubation Duration 3 Hours Overnight Overnight Overnight 
 
 
To investigate the activity of 2-methylcitrate synthase, PrpC, four separate 
reactions were carried out, a complete PrpC reaction, a complete PrpC reaction minus 
oxaloacetate, a complete PrpC reaction minus propionyl-CoA, and 1mM 2-methylcitrate 
standard. The substrates and buffers in the complete PrpC reaction were combined to 
reach the following final concentrations: 0.25 mM propionyl-CoA, 2 mM oxaloacetate, 
10 mM HEPES buffer, and 75 µL of PrpC protein. Negative controls were carried out to 
ensure the observed peaks were not due to contaminants. The volume of propionyl-CoA 
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and oxaloacetate was replaced with 10 mM HEPES buffer in the PrpC reaction minus 
propionyl-CoA and PrpC reaction minus oxaloacetate respectively. Neither of these 
reactions displayed any new peaks between the 10-25 minute time range. The 2-
methylcitrate standard was prepared by combining 50 µL of commercially provided 20 
mM 2-methylcitrate to 950 µL of 10 mM HEPES buffer to obtain a final concentration of 
1 mM 2-methylcitrate. All reactions, with the exception of the 2-methylcitrate standard, 
which was prepared and quenched just before injection, were incubated overnight and 
quenched using 1M sodium phosphate. The reactions were centrifuged at 13,000 rpm for 
5 minutes before injection. 
 To further investigate the stereochemistry of the product of PrpC, also the 
substrate for PrpD in the subsequent step, a reaction with PrpD and the commercially 
obtained 2-methylcitrate as the only substrate was carried out. 
2.4.2 “Cross-species” Activity Assays with MCC Enzymes from ECK12 and BS168 
 To compare the products of 2-methylcitrate synthase in ECK12 (PrpC) to the 
homologous enzyme in BS168 (MmgD), interspecies experiments were conducted with 
the subsequent enzymes in the MCC pathway, specifically PrpD from ECK12 and MmgE 
from BS168. The PrpC/MmgE reaction was prepared with the following final 
concentrations of enzymes, substrates, and buffer: 0.25 mM propionyl-CoA, 2 mM 
oxaloacetate, 10 mM HEPES buffer, and 75 µL of each enzyme. The reaction was 
incubated overnight, followed by the addition of 100 µL of 1M sodium phosphate buffer 
with a pH=2.9 and centrifugation for 5 minutes before injection into the HPLC. To 
provide further evidence of homology of these particular enzymes within the MCC 
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pathway, a 1mL reaction was prepared which contained 75µL of each enzyme (MmgD 
and PrpD), 25 µL of 10 mM propionyl-CoA, 100 µL of 20 mM oxaloacetate, and the 
remaining volume made up by 10 mM HEPES buffer with a pH= 7.2. After overnight 
incubation, the reaction was quenched with 100 µL of 1M sodium phosphate buffer (pH-
2.9) and centrifuged for 5 minutes before analysis.
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CHAPTER III 
RESULTS AND DISCUSSION 
 
 
3.1 Electrophoresis Gel Results for Genes and Transformants 
3.1.1 Electrophoresis Gel of ECK12 Genomic DNA with prpC Primers 
Pictured in Figure 5 is an electrophoresis gel of the PCR product using the 
previously described prpC primers and isolated genomic DNA from ECK12. Due to the 
length of the gene sequence of prpC and prpD, the annealing period was extended from 
45 to 75 seconds to optimize PCR settings. The gel displayed a strong band between 1.2 
and 1.0 kilobasepairs, which correlated with the expected length of the prpC sequence 
length, 1.17 kilobasepairs. 
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Figure 5. Electrophoresis Gel of prpC Gene Sequence Product in ECK12. Lane 1: 
PCR product with prpC forward and reverse primers; Lane 3: 2-Log DNA Ladder with 
corresponding lengths of the fragments in kilobasepairs. 
 
3.1.2 Electrophoresis Gel of ECK12 Genomic DNA with prpD Primers 
The gel depicted in Figure 6 shows a strong band at approximately 1.5 
kilobasepairs, which correlated with the expected length of the prpD gene sequence, 
1.452 kilobasepairs. 
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Figure 6. Electrophoresis Gel of prpD Gene Sequence Product in ECK12. Lane 1: 
PCR product with prpD forward/reverse primers; Lane 2: 2-Log DNA Ladder with 
corresponding lengths of fragments in kilobasepairs. 
 
3.1.3 Cloning: Challenges and Solutions 
The manufacturer’s instructions provide a molar ratio of PCR product to TOPO 
vector for successful transformation. In order to quantify the yield of the prpC PCR 
product, intensities between the PCR product and the 2-Log DNA ladder were measured. 
A 1:1 molar ratio was achieved by measuring band intensities using gel camera software 
with comparison to a DNA ladder having known quantities of each standard.  
Transformants were initially screened using the gene sequence primers, 
prpC/prpD forward and reverse. Due to the primers being non-specific to the gene ligated 
into the vector, the primers returned false positive results from a contaminating sequence 
or genomic DNA in the reactions. Introducing the T7 primer, in addition to one of the 
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gene primers, provided a more successful screening method. Illustrated in Figure 7, is a 
diagram of the pET-200 TOPO® vector that displays the location of the TOPO reaction 
and gene insertion, as well as the T7 primer binding locations. 
 
 
 
Figure 7. A Depiction of the pET200/D-TOPO Vector with prpC or prpD Gene 
Insertion. Note location of T7 and T7 terminal primers.19 
 
 
The T7 reverse primer and prpC forward primer were used to detect successful 
gene insertion into the plasmid, which is displayed in Figure 8. In addition, Figure 9 
displays the electrophoresis gel obtained using T7 forward and prpC reverse primers 
were used to revalidate the results obtained in Figure 8. The electrophoresis gel depicted 
in Figure 9 confirms a successful insertion of the gene prpC into the vector containing 
antibiotic resistance, pET-200 plasmid. The proper insertion of the gene into the plasmid 
was confirmed by sequencing data obtained from Eurofins Genomics. 
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Figure 8. Electrophoresis Gel of prpC Transformant. Lane 1: PCR product with prpC 
forward/reverse primers and isolated genomic DNA; Lane 2: prpC transformant with 
prpC forward and T7 reverse primers; Lane 3: 2-Log DNA Ladder with corresponding 
lengths of fragments. 
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Figure 9. Electrophoresis Gel of prpC Transformant Screened with Forward T7 and 
Reverse Gene Primer. Lane 1: PCR product with prpC forward/reverse primers and 
isolated genomic DNA; Lane 2: prpC transformant with prpC reverse and T7 forward 
primers; Lane 3: 2-Log DNA Ladder with corresponding lengths of fragments in 
kilobasepairs. 
 
To determine successful ligation, PCR products were obtained using T7 forward 
and prpD reverse primers on the purified plasmid DNA shown in Figure 10. Purified 
plasmid samples 1, 2, and 4 exhibited positive results for the desired clone using the 
plasmid specific primers and were then sequenced. Based on the sequencing results 
generated by Eurofins Genomics, it was confirmed that only purified plasmid sample # 4 
contained the prpD gene sequence, in addition to the His-tag and proper frame 
configuration. 
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Figure 10. Electrophoresis Gel of prpD Transformant with T7 Forward and prpD 
Reverse Primers. Lane 1: Purified plasmid # 1 PCR product with T7 forward and prpD 
reverse primers; Lane 2: Purified plasmid # 2 PCR product with T7 forward and prpD 
reverse primers; Lane 4: Purified plasmid # 4 PCR product with T7 forward and prpD 
reverse primers; Lane 6: 2-Log DNA Ladder with corresponding kilobasepairs. 
 
3.2 Protein Expression and Purification Optimization 
In order to optimize large culture growth conditions, the temperature, quantity of 
IPTG, and duration of growth were all varied. The most successful PrpC and PrpD 
cultures were induced with 1 mM IPTG when the absorbance value rose between 0.5 to 
0.6 range at 595 nm and the culture was allowed to grow overnight. PrpD did not exhibit 
any post column precipitation. In contrast, PrpC exhibited precipitation after purification 
using Ni-NTA affinity chromatography. This obstacle was overcome by altering the 
elution buffer from 1000 mM to 200 mM imidazole. Some precipitation was still 
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observed, but enough protein stayed in solution to be used in further analysis. To verify 
the identity and purity of the protein, an SDS-PAGE gel was conducted and pictured in 
Figure 11. The gel exhibits an intense band between the 50 and 40 kDa fragment in the 
protein ladder, which correlates with the expected protein size of PrpC, 43.102 kDa. 
 
 
 
Firgure 11. 10 % Tris-glycine SDS-PAGE Gel of PrpC Protein. Lane 1: 20 µL of the 
sample containing: 50 µL of protein and 50 µL of Laemmli Sample Buffer with the 
corresponding molecular weights of the protein ladder; Lane 2: Unstained Protein 
Ladder, Broad Range (10-250 kDa). 
 
The image shown in Figure 12, displays an intense band at the expected PrpD 
mass of 54.0 kDa. 
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Figure 12. 10 % Tris-glycine SDS-PAGE Gel of PrpD Protein. Lane 1: 20 µL of the 
sample containing: 15 µL of protein and 85 µL of Laemmli Sample Buffer; Lane 2: 
Unstained Protein Ladder, Broad Range (10-250 kDa) with the corresponding molecular 
weights of the protein ladder. 
 
3.3 Activity Reconstitution 
 Several HPLC reaction modifications played an integral role in obtaining 
successful assay results, such as extending the incubation period, increasing the volume 
of the enzyme used in the reaction, and changing the reaction buffer from Tris-HCl buffer 
to 10 mM HEPES buffer. The Tris-HCl buffer was found to react with oxaloacetate, 
which interfered with the production of the stereoisomers of interest. 
Although the activity of PrpC and PrpD have been previously investigated, recent 
work with homologous enzymes in B. subtilis have revealed stereochemical discrepancies 
between the products catalyzed by these similar enzymes that share an amino acid 
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sequence and overall similarity. Previous results obtained in the Reddick laboratory 
characterized the activity of enzymes encoded within the mmg operon in B. subtilis. 
Specifically, MmgD demonstrated 2-methylcitrate synthase activity by producing (2S, 
3R)-2-methylcitrate or (2R, 3S)-2-methylcitrate. MmgE exhibited dehydratase activity 
using one of the heterochiral stereoisomers to produce (Z)-2-methylaconitate. The same 
methodology used with the B. subtilis enzymes was applied to the E. coli enzymes to 
further explore the reaction products of 2-methylcitrate synthase and dehydratase. 
Although HPLC is unable to distinguish between enantiomers, diastereomers 
exhibit different elution times. Results from the full PrpC reaction demonstrate that the 
product is one of the heterochiral (2S, 3R) or (2R, 3S)-2-methylcitrate diastereomers. 
Furthermore, there is no observable product peak at the elution time of the homochiral 2-
methylcitrate products. These results are shown in Figure 13B. The injection of 
commercial 2-methylcitrate showed two major peaks at 12.4 and 14.7 minutes, which 
correlates with the precedent set forth in the literature and the Sigma-Aldrich 
stereochemical assignment with the heterochiral products, (2R, 3S)/(2S, 3R) set of 
diasteromers eluting at 12.4 minutes and the homochiral products, (2R, 3R)/(2S, 3S) set of 
diasteromers eluting at 14.7 minutes, as illustrated in Figure 13A. The full PrpC reaction 
exhibited only one new product peak at 12.5 minutes, therefore, PrpC is only producing 
one of the (2R, 3S)/(2S, 3R) diasteromers in these reaction conditions, as shown in Figure 
13B. 
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Figure 13. HPLC Chromatograms of 2-Methylcitrate Standard and PrpC. A: The 
commercially available 2-methylcitrate standard in a racemic mixture of 4 enantiomers, 
eluting as the heterochiral pair, (2R, 3S)/(2S, 3R), and the homochiral pair, (2R, 3R)/(2S, 
3S). B: The chromatogram of the complete PrpC reaction with the substrates propionyl-
CoA and oxaloacetate showing a new product peak eluting at 12.5 minutes. 
 
Experiments that contained the 2-methylcitrate racemate and PrpD were 
conducted to further validate the product of PrpC. The chromatogram produced from the 
reaction with PrpD and the commercial 2-methylcitrate racemate is shown in Figure 14B. 
To test the hypothesis that PrpC was only producing one of the heterochiral 
diastereomers, the full PrpC reaction, in which the only substrates included were 
propionyl-CoA and oaxaloacetate as mentioned previously, was combined with PrpD and 
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the activity was measured. There was only one observable new product peak at 15.0 
minutes, which corresponded with (Z)-2-methylaconitate. 
 
 
 
Figure 14. HPLC Chromatograms of 2-Methylcitrate, PrpC, and PrpD. A: The 
chromatogram of the commercially available 2-methylcitrate with elution times similar to 
those illustrated in Figure 13A. B: The chromatogram of the full PrpD reaction with the 
commercial 2-methylcitrate (2 sets of diastereomer pairs) as the only substrate source. 
The active peaks at 12.2 and 14.5 minutes indicate unreacted starting material. The new 
product peaks at 14.7 and 17.7 minutes correspond to the (Z)-2-methylaconitate and (E)-
2-methylaconitate respectively. C: Chromatogram of full PrpC and PrpD reaction with 
propionyl-CoA and oxalacetate only as the substrates displaying one new product peak at 
15.0 minutes. 
 
	  34	  
Based on the chromatogram in Figure 14B, PrpD is not only capable of producing 
the (Z)-2-methylaconitate product, it can also produce the (E)-2-methylaconitate 
stereoisomer when other stereoisomers of 2-methylcitrate are available. This data points 
to the conclusion that PrpD does not possess rigid stereoselectivity in regards to 
substrates. 
The chromatogram of a full PrpC and PrpD reaction is shown in Figure 14C, 
which displays a single product peak at the 15.0 minute elution time. This product peak 
coincides with (Z)-2-methylaconitate, which eluted at 14.7 minutes in a previous reaction 
containing commercially available 2-methylcitrate and PrpD. This data supports the 
notion that PrpC is only producing one of the stereoisomers; otherwise PrpD would be 
able to produce both (Z)-2-methylaconitate and (E)-2-methylaconitate if multiple 
substrate stereoisomers were supplied by PrpC, as seen in Figure 14B. 
The cross-species experiments demonstrated the compatibility of homologous 
enzymes involved in the MCC. HPLC chromatograms displaying a 10-20 minute elution 
time scale are shown in Figure 15A and 15B and both illustrate a single product peak at 
14.9 minutes, which correlates with the (Z)-2-methylaconitate stereoisomer. There were 
no additional product peaks, which would have been observed if PrpC had the capability 
of producing more than one 2-methylcitrate stereoisomer. The results obtained from these 
cross-species experiments further support the notion that PrpC from ECK12 and MmgD 
from BS168 are homologous in functionality and produce the same 2-methylcitrate 
stereoisomer, otherwise they would not demonstrate compatibility with the other species’ 
2-methylcitrate dehydratase (PrpD/ MmgE). The results of these cross-species 
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experiment using MmgD from BS168 and PrpD from ESK12 are illustrated in Figure 
15B. 
 
 
 
Figure 15. HPLC Chromatograms of “Cross-Species” Reactions with ECK12 and 
BS168 Enzymes. A: HPLC chromatogram of a “cross-species” reaction containing PrpC 
from E. coli and MmgE from B. subtilis displaying a single active peak at 14.9 minutes. 
B: The chromatogram of the “cross-species” reaction containing MmgD from B. subtilis 
and PrpD from E. coli with an active peak at 14.9 minutes. 
 
3.4 Conclusion 
Due to the lax specificity PrpD and MmgE exhibit, these two enzymes possess the 
ability to catalyze at least two stereoisomers of 2-methylcitrate. Therefore, if either of the 
2-methylcitrate synthases (PrpC/MmgD) were producing a homochiral (2SR, 3SR)-2-
methylcitrate product, a product peak would be observed where (E)-2-methylaconitate 
elutes, approximately 17.7 minutes. Based on this reasoning, MmgD nor PrpC are 
producing either version of the homochiral products. The possible reaction product of 
MmgD and PrpC can now be narrowed to either (2S, 3R) or (2R, 3S)-2-methylcitrate.
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